Iovance appoints Wendy L. Yarno to Board; Wendy L. Dixon not standing for re-election

IOVANCE BIOTHERAPEUTICS, INC.

Wendy L. Yarno appointed as director effective April 18, 2023; previously EVP & CMO at Merck over 26 years.
Wendy L. Dixon will not stand for re-election at June 2023 annual meeting; will serve until meeting ends.
Board increased from 7 to 8 members for Yarno's seat; will reduce back to 7 after annual meeting.
Yarno granted standard deferred restricted stock unit per new-director compensation; no related-party transactions.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Wendy L. Dixon

director

IOVA · IOVANCE BIOTHERAPEUTICS, INC.

Filed: April 24, 2023, 7:59 PM ET

Wendy L. Dixon, a member of the Board, will not be standing for re-election to the Board at the Company’s annual meeting of stockholders currently anticipated to be held in June 2023.

Appointed

Wendy L. Yarno

director

IOVA · IOVANCE BIOTHERAPEUTICS, INC.

Effective: 2023-04-18
Filed: April 24, 2023, 7:59 PM ET

appointed Wendy L. Yarno as a director and new member of the Board, effective April 18, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Wendy L. Dixon departed as director at IOVANCE BIOTHERAPEUTICS, INC..

Action: will not be standing for re-election
Role: director

Exact text from the filing

Wendy L. Dixon, a member of the Board, will not be standing for re-election to the Board at the Company’s annual meeting of stockholders currently anticipated to be held in June 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Wendy L. Yarno was appointed as director at IOVANCE BIOTHERAPEUTICS, INC..

Action: appointed
Role: director

Exact text from the filing

appointed Wendy L. Yarno as a director and new member of the Board, effective April 18, 2023.

View on SEC.gov

IOVANCE BIOTHERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-049060

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.